Skip to main content

Table 4 Functional bothers and their association with treatment type, SA-PCCOC registry (2010–2019)

From: Patient-reported functional outcome measures and treatment choice for prostate cancer

Rx

Sexual bother

 

Urinary bother

 

Bowel bother¥

aOR‡

95% CI

 

aOR‡

95% CI

 

aOR‡

95% CI

RP

reference

  

reference

  

reference

 

EBRT

0.51

0.29, 0.89*

 

0.75

0.49, 1.15

 

2.01

1.23, 3.29**

BT

0.68

0.36, 1.27

 

0.76

0.41, 1.41

 

-

-

AS

0.60

0.38, 0.96*

 

0.64

0.40, 1.03

 

1.16

0.67, 2.02

  1. Rx, treatment type; RP, radical prostatectomy; EBRT, external beam radiation therapy; BT, brachytherapy; AS, active surveillance; CI, confidence interval
  2. The models were adjusted for inverse probability weight, baseline bother of the respective function, age, SEIFA score, PSA level, risk category and primary symptoms
  3. All analyses were with the weighted sample
  4. aOR, adjusted odds ratio from ordinal logistic regression models of 12-month post-treatment bothers (five categories: no, very small, small, moderate and big bothers)
  5. ¥The brachytherapy group was not included in the model because there were very small counts in brachytherapy group
  6. *p < 0.05, **p < 0.01, ***p < 0.001